Drug Class
JAK inhibitor and BCL-2 family inhibitor combination
Type
brand
Active Ingredient
pacritinib
📋Overview
Vonjo is a medication known as a JAK2 inhibitor. It is primarily associated with the management of certain blood disorders, particularly myelofibrosis, a rare type of bone marrow cancer. Vonjo works by targeting specific pathways involved in the abnormal growth of blood cells. Its use is generally linked to conditions where there is an overproduction of blood cells or scarring of the bone marrow.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Vonjo
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.